NEXTURN&ROLLKOREA Co., Ltd

KOSDAQ:A089140 Stock Report

Market Cap: ₩35.7b

NEXTURN&ROLLKOREA Balance Sheet Health

Financial Health criteria checks 5/6

NEXTURN&ROLLKOREA has a total shareholder equity of ₩232.7B and total debt of ₩91.3B, which brings its debt-to-equity ratio to 39.2%. Its total assets and total liabilities are ₩353.3B and ₩120.6B respectively.

Key information

39.22%

Debt to equity ratio

₩91.27b

Debt

Interest coverage ration/a
Cash₩54.06b
Equity₩232.73b
Total liabilities₩120.59b
Total assets₩353.32b

Recent financial health updates

Recent updates

NEXTURN&ROLLKOREA (KOSDAQ:089140) Has Debt But No Earnings; Should You Worry?

Nov 14
NEXTURN&ROLLKOREA (KOSDAQ:089140) Has Debt But No Earnings; Should You Worry?

Take Care Before Diving Into The Deep End On NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

Apr 09
Take Care Before Diving Into The Deep End On NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 38% Share Price Plunge Could Signal Some Risk

Dec 02
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 38% Share Price Plunge Could Signal Some Risk

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

Aug 13
Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Mar 28
NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Jan 25
Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Financial Position Analysis

Short Term Liabilities: A089140's short term assets (₩95.9B) exceed its short term liabilities (₩95.7B).

Long Term Liabilities: A089140's short term assets (₩95.9B) exceed its long term liabilities (₩24.9B).


Debt to Equity History and Analysis

Debt Level: A089140's net debt to equity ratio (16%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if A089140's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable A089140 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: A089140 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 40% per year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/15 21:54
End of Day Share Price 2025/11/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NEXTURN&ROLLKOREA Co., Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
KYUNG SEOB KIMShinhan Investment Corp.
Sun Hwa LeeSK Securities Co., Ltd.